Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FBEN9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,573
Award facts
- Contract value 100% obligated
- $11,573.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,573.28 delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pens (2 mL quantity) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed price contract was competitively awarded without a set-aside designation and will be performed in Conshohocken, Pennsylvania. The delivery order represents a pediatric and adult biologic immunosuppressant medication commonly used to treat moderate-to-severe atopic dermatitis, eczema, and other inflammatory conditions within military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has demonstrated significant capability in federal medical procurement through its extensive portfolio of competitively awarded contracts with DLA and its ability to fulfill specialized pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FBEN9?
SPE2DB25FBEN9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FBEN9 worth?
The government has obligated $11,573 on SPE2DB25FBEN9.
Is contract SPE2DB25FBEN9 an order under another contract?
Yes. SPE2DB25FBEN9 is a delivery order under SPE2DB22D3016, an indefinite delivery contract.
Was contract SPE2DB25FBEN9 competed?
The extent of competition for SPE2DB25FBEN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award